Pulmonary Cell News Volume 11.06 | Feb 17 2022

    0
    20







    2022-02-17 | PULCN 11.06


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 11.06 – 17 February, 2022
    TOP STORY

    KIX Domain Determines a Selective Tumor-Promoting Role for EP300 and Its Vulnerability in Small Cell Lung Cancer

    Scientists demonstrated that EP300 mutants lacking acetyltransferase domain accelerated tumor development in mouse models of SCLC.
    [Science Advances]

    Full Article
    Explore Antibodies for Epithelial Cell Markers
    PUBLICATIONSRanked by the impact factor of the journal

    Regulation of MHC Class I Expression in Lung Epithelial Cells during Inflammation

    The authors reported that inhalation of the TLR4 ligand LPS upregulated cell surface MHC class I by ∼25-fold on the three subtypes of mouse lung epithelial cells.
    [Journal of Immunology]

    Abstract

    IRE1α Drives Lung Epithelial Progenitor Dysfunction to Establish a Niche for Pulmonary Fibrosis

    Kinase inhibitor of IRE1α treatment increased the differentiation of Krt19CreERT2-lineage-traced damage-associated transient progenitors (DATPs) into type 1 alveolar epithelial cells after bleomycin injury, indicating that relief from IRE1α signaling enabled DATPs to exit the transitional state.
    [American Journal of Physiology-Lung Cellular and Molecular Physiology]

    Abstract

    miR-520a-5p Regulates Frizzled 9 Expression and Mediates Effects of Cigarette Smoke and Iloprost Chemoprevention

    Researchers found that miR-520a-5p bound the Frizzled 9 (FZD9) 3’UTR in lung cell lines and altered activity and expression of FZD9 downstream targets.
    [Scientific Reports]

    Full Article

    Nifuroxazide Ameliorates Pulmonary Fibrosis by Blocking Myofibroblast Genesis: A Drug Repurposing Study

    In vivo, intraperitoneal injection of nifuroxazide relieved and reversed pulmonary fibrosis caused by bleomycin bronchial instillation.
    [Respiratory Research]

    Full ArticleGraphical Abstract

    Particulate Matter-Induced Hypomethylation of Alu and LINE1 in Normal Human Bronchial Epithelial Cells and Epidermal Keratinocytes

    Investigators quantitatively measured the methylation content of Alu and LINE1 in particulate matter-treated normal human bronchial epithelial cells and normal human epidermal keratinocytes by using whole-genome bisulfite sequencing and pyrosequencing.
    [Genes and Environment]

    Full Article

    Knockdown of circRNA Paralemmin 2 Ameliorates Lipopolysaccharide-Induced Murine Lung Epithelial Cell Injury by Sponging miR-330-5p to Reduce ROCK2 Expression

    CircRNA paralemmin 2 modulated lipopolysaccharide-caused murine lung epithelial cell injury by the microRNA-330-5p (miR-330-5p)/rho-associated coiled-coil containing protein kinase 2 (ROCK2) pathway, providing a therapeutic target for acute lung injury.
    [Immunological investigations]

    Abstract

    E2F1-Induced lncRNA, EMSLR Regulates lncRNA LncPRESS1

    The authors carried out genome-wide transcriptome analysis and discovered an lncRNA, EMSLR, which was induced both in lung adenocarcinoma and lung squamous cell carcinoma.
    [Scientific Reports]

    Full Article

    Berberine-Loaded Liquid Crystalline Nanoparticles Inhibit Non-Small Cell Lung Cancer Proliferation and Migration In Vitro

    Investigators formulated berberine-loaded liquid crystalline nanoparticles and investigated their in vitro antiproliferative and antimigratory activity in a human lung epithelial cancer cell line.
    [Environmental Science and Pollution Research]

    Full Article

    Serum IL-35 Levels Is a New Candidate Biomarker of Cancer-Related Cachexia in Stage IV Non-Small Cell Lung Cancer

    Scientists revealed that high serum IL-35 expression was associated with NSCLC cachexia and skeletal muscle atrophy.
    [Thoracic Cancer]

    Full Article

    Watch this webinar to learn the advantages of using primary human nasal epithelial cells to study Cystic Fibrosis.
    REVIEWS

    The PI3K/Akt/mTOR Pathway in Lung Cancer; Oncogenic Alterations, Therapeutic Opportunities, Challenges, and a Glance at the Application of Nanoparticles

    The authors summarize the original data obtained from international research laboratories on the oncogenic alterations in each component of the PI3K/Akt/mTOR pathway in lung cancer.
    [Translational Oncology]

    Full ArticleGraphical Abstract

    Selumetinib: A Selective MEK1 Inhibitor for Solid Tumor Treatment

    The efficacy of selumetinib in various solid tumors such as colorectal cancer, lung cancer, neurofibroma, and melanoma is investigated.
    [Clinical and Experimental Medicine]

    Abstract
    INDUSTRY AND POLICY NEWS

    Genetron Health Announces Companion Diagnostic Collaboration Agreement with HUTCHMED’s ORPATHYS® for NSCLC

    Genetron Holdings Limited announced that it has signed a collaboration agreement with HUTCHMED Limited for the joint development of a companion diagnostic test for ORPATHYS® in China.
    [Genetron Holdings Limited]

    Press Release

    Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China

    Zai Lab Limited announced that the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough Therapy Designation for investigational repotrectinib for the treatment of patients with ROS1-positive metastatic NSCLC who have not been treated with a ROS1 tyrosine kinase inhibitor.
    [Zai Lab Limited]

    Press Release
    FEATURED EVENT

    Sy-Stem 2022

    March 20 – March 25
    Vienna, Austria

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Functional Genomics of Lung Cancer

    University of California San Francisco – San Francisco, California, United States

    Postdoctoral Research Scientist – Immunology

    Babraham Institute – Babraham, Cambridgeshire, United Kingdom

    Postdoctoral Positions – Translational 3D Pathology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Researcher – 3D Advanced Microscopy

    IRB Barcelona – Barcelona, Spain

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter